Acadian Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.08M | Buy |
|
|||||
|
2025
Q1 | $1.7M | Sell |
|
|||||
|
2024
Q4 | $2.03M | Buy |
|
|||||
|
2024
Q3 | $892K | Buy |
|
|||||
|
2024
Q2 | $994K | Buy |
|
|||||
|
2024
Q1 | $221K | Buy |
|
|||||
|
2023
Q4 | $184K | Sell |
|
|||||
|
2023
Q3 | $325K | Buy |
|
|||||
|
2023
Q2 | $175K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1M | Buy |
|
|||||
|
2022
Q1 | $32K | Buy |
|
|||||
|
2021
Q4 | $7K | Sell |
|
|||||
|
2021
Q3 | $24.8M | Buy |
|
|||||
|
2021
Q2 | $3.05M | Buy |
|
|||||
|
2021
Q1 | $1.43M | Sell |
|
|||||
|
2020
Q4 | $3.8M | Buy |
|
|||||
|
2020
Q3 | $1.8M | Buy |
|
|||||
|
2020
Q2 | $2.54M | Buy |
|
|||||
|
2020
Q1 | $83K | Buy |
|